Iovance trims workforce after cell therapy sales missed expectationsnews2025-08-07T01:51:50+00:00August 7th, 2025|Endpoints News|
Elevidys sales fall again in Sarepta’s second quarter amid safety issuesnews2025-08-07T00:55:35+00:00August 7th, 2025|Endpoints News|
Sixth Circuit judges uphold IRA decision in government’s favornews2025-08-06T20:56:32+00:00August 6th, 2025|Endpoints News|
FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout news2025-08-06T19:43:30+00:00August 6th, 2025|Endpoints News|
Novo Nordisk, Sanofi, Lilly to face renewed fight over alleged 340B price fixingnews2025-08-06T19:31:28+00:00August 6th, 2025|Endpoints News|
OpenAI-backed biotech Chai Discovery raises $70M Series Anews2025-08-06T18:21:23+00:00August 6th, 2025|Endpoints News|
Novavax expects Phase 4 Covid trial to cost up to $90Mnews2025-08-06T18:05:52+00:00August 6th, 2025|Endpoints News|
BridgeBio’s Attruby sales underwhelm Wall Street despite growthnews2025-08-06T15:45:32+00:00August 6th, 2025|Endpoints News|
Precision’s early HBV gene editing data are mixed as biotech lays off staff to save cashnews2025-08-06T15:25:20+00:00August 6th, 2025|Endpoints News|
Amgen CEO says compounding is ‘less a direct issue’ for obesity drug MariTidenews2025-08-06T15:23:26+00:00August 6th, 2025|Endpoints News|
